Per- and polyfluoroalkyl substances (PFAS) have been linked to increased cancer risk in numerous epidemiological studies. Understanding these associations helps individuals and communities make informed decisions about water filtration and exposure reduction.
Which Cancers Are Associated With PFAS Exposure?
Research has identified several cancers with statistically significant associations to PFAS exposure. Kidney cancer and testicular cancer show the strongest and most consistent links across multiple studies. These associations held even after controlling for other risk factors such as smoking, obesity, and occupational exposures.
Bladder cancer, non-Hodgkin lymphoma, and breast cancer have also shown associations in some studies, though the evidence is less consistent. Researchers continue to investigate the dose-response relationships to better understand at what exposure levels risk begins to increase meaningfully.
How Might PFAS Cause Cancer?
Several biological mechanisms have been proposed to explain PFAS carcinogenicity. PFAS can activate peroxisome proliferator-activated receptors (PPARs), which regulate cell growth and metabolism. Dysregulation of these receptors may promote abnormal cell proliferation. Additionally, PFAS have been shown to disrupt hormonal signaling pathways, alter immune surveillance, and induce oxidative stress — all of which can contribute to cancer development.
Animal studies have demonstrated that high-dose PFAS exposure causes liver tumors, testicular tumors, and pancreatic tumors. While human exposures are typically lower than those used in animal studies, chronic low-level exposure over decades is a concern that researchers take seriously.
PFOA and PFOS: The Most Studied Compounds
PFOA (perfluorooctanoic acid) and PFOS (perfluorooctane sulfonate) are the most extensively studied PFAS compounds for cancer risk. The International Agency for Research on Cancer (IARC) classified PFOA as possibly carcinogenic to humans (Group 2B) in 2023, reflecting growing evidence from epidemiological studies.
Communities near PFAS manufacturing facilities — such as those around DuPont’s Washington Works plant in West Virginia and 3M’s Cottage Grove facility in Minnesota — provided crucial data. Elevated rates of kidney and testicular cancer among residents with high PFAS exposure contributed significantly to current understanding of these risks.
Reducing Cancer Risk Through Water Filtration
Since drinking water is a primary route of PFAS exposure for many people, using certified water filtration systems represents one of the most practical risk-reduction strategies. Reverse osmosis systems remove 90–99% of PFAS from drinking water, while activated carbon filters provide meaningful but variable reductions depending on the specific compounds and filter design.
The EPA’s 2024 Maximum Contaminant Levels for six PFAS compounds reflect the regulatory framework designed to limit exposure through public water systems. For those on private wells, independent testing and appropriate filtration remain essential protective measures.
The Ongoing Research Landscape
Cancer risk from PFAS remains an active area of research. Ongoing cohort studies are following exposed populations for decades to better characterize lifetime risk. As analytical methods improve and more PFAS compounds are studied, the full scope of cancer associations may expand beyond what current evidence shows.
For individuals concerned about PFAS-related cancer risk, consulting with healthcare providers about monitoring and testing, combined with practical exposure reduction through water filtration, represents a balanced approach to protecting long-term health.